The most commonly reported treatments were anti-immunoglobulin E (anti-IgE or ‘biological therapy’) and generic terms as ‘new therapies’, ‘innovative therapies’ for the treatment of allergic asthma, and ICS-LABA for the treatment of intrinsic asthma. The gene discussed is IGHE; the disease is asthma.